✦ LIBER ✦

Early change in bone resorption predicts discontinuation of tumor necrosis factor-alpha blocking therapy in patients with ankylosing spondylitis

✍ Scribed by S. Arends; A. Spoorenberg; P.M. Houtman; M.K. Leijsma; C.G. Kallenberg; E. Brouwer; E. van der Veer⁎

Book ID: 116325704
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 72 KB
Volume: 50
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2012.02.600

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rehabilitation Treatment in Patients wit

Rehabilitation Treatment in Patients with Ankylosing Spondylitis Stabilized with Tumor Necrosis Factor Inhibitor Therapy. A Randomized Controlled Trial

✍ MASIERO, S.; BONALDO, L.; PIGATTO, M.; LO NIGRO, A.; RAMONDA, R.; PUNZI, L. 📂 Article 📅 2011 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 416 KB

The comparative effectiveness of tumor n

The comparative effectiveness of tumor necrosis factor–blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: A six-month, longitudinal, observational, multicenter study

✍ Marte S. Heiberg; Bjørn-Yngvar Nordvåg; Knut Mikkelsen; Erik Rødevand; Cecilie K 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

T Cell Subsets in Unstimulated Periphera

T Cell Subsets in Unstimulated Peripheral Blood of Patients with Ankylosing Spondylitis: Tumor Necrosis Factor-alpha Blockers Decrease Th1 and Th17 Subpopulations

✍ Leonardo Limón-Camacho; María Inés Vargas-Rojas; Ruben Burgos-Vargas; Luis Llore 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Magnetic resonance imaging examinations

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor α receptor fusion protein etanercept

✍ X. Baraliakos; J. Davis; W. Tsuji; J. Braun 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

Differences in the incidence of flares o

Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti–tumor necrosis factor α agents

✍ Braun, J. ;Baraliakos, X. ;Listing, J. ;Davis, J. ;van der Heijde, D. ;Haibel, H 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## Objective Ankylosing spondylitis (AS) and inflammatory bowel disease (IBD) are clinically and pathologically linked. Anti–tumor necrosis factor (anti‐TNF) agents are efficacious in treating AS, but not all are equally effective in treating IBD (Crohn's disease [CD] and ulcerative co

Single-center series and systematic revi

Single-center series and systematic review of randomized controlled trials of malignancies in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis receiving anti-tumor necrosis factor α therapy: Is there a need for more comprehensive screening procedures?

✍ Nannini, Carlotta ;Cantini, Fabrizio ;Niccoli, Laura ;CassarÀ, Emanuele ;Salvara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views